Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 14.55
-0.15 (-1.02%)
Apr 20, 2026, 12:11 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 643.44 million as of April 20, 2026. Its market cap has increased by 6.52% in one year.
Market Cap
643.44M
Enterprise Value
467.58M
Revenue
67.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.55
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 643.44M, an increase of 63.63%. That is a compound annual growth rate of 3.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 643.44M | 5.00% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 1.13B |
| Taiwan Advance Bio-Pharmaceutical | 1.13B |
| Level Biotechnology | 1.09B |
| Lukas Biomedical | 1.03B |
| TCI GENE | 967.06M |
| NatureWise Biotech & Medicals | 900.10M |
| BioLASCO Taiwan | 778.60M |
| Neith | 749.77M |